-

AM Best to Present and Exhibit at IASA Xchange 2024

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best will deliver a presentation and exhibit at the IASA Xchange 2024, which will take place June 2-5, 2024, in Pittsburgh, PA, June 2-5, 2024.

At the event, AM Best Senior Director of Credit Rating Criteria Research & Analytics Robert Raber will lead a speaking engagement titled, “AM Best’s View of the Critical Function of Stress Testing.” The presentation will frame stress testing in the structure of AM Best’s rating methodology, including the impact on ratings, observed best practices and expectations going forward.

In addition, AM Best representatives will be at booth No. 202 to discuss a wide range of products and services, including:

  • Best’s Insurance Reports®, which offers detail and analysis behind Best's Credit Ratings, the latest financial data and company information, along with tools and features to enhance your research.
  • Best’s Financial Suite, which supports sophisticated insurer analysis with quality financial data, credit ratings and tools.
  • Best’s News & Research Service, providing a fresh perspective on the global insurance industry.
  • Best’s State Rate Filings®, which helps you keep up with US P/C and L/H program innovations, find out which competitors are entering which markets, and create targeted product development strategies.
  • Best’s Alert Service, which provides immediate notification of changes to ratings, key financial data and other company information.
  • BestESP®, AM Best's enhanced electronic statement preparation application that offers a streamlined filing experience and no hidden fees.

The IASA is a non-profit, education association that seeks to create and provide to its members and participants a framework for best practices in certain insurance industry disciplines such as accounting, finance, risk management, investments, operations, technology and career skills. The IASA Xchange is designed for all career levels and specialties, including claims, risk, finance, accounting, enterprise risk management and technology.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2024 by A.M. Best Company, Inc. and/or its affiliates.
ALL RIGHTS RESERVED.

Contacts

Christopher Sharkey
Associate Director, Public Relations
+1 (908) 442-9229
christopher.sharkey@ambest.com

Industry:

AM Best

Release Versions
English
Hashtags
#insurance

Contacts

Christopher Sharkey
Associate Director, Public Relations
+1 (908) 442-9229
christopher.sharkey@ambest.com

Social Media Profiles
AM Best Rating Services on LinkedIn
AM Best Ratings Twitter
AM Best Co.
AM Best on YouTube
More News From AM Best

AM Best Assigns Credit Ratings to Charp Re, Ltd.

MEXICO CITY--(BUSINESS WIRE)--AM Best has assigned a Financial Strength Rating of B++ (Good) and a Long-Term Issuer Credit Rating (Long-Term ICR) of “bbb” (Good) to Charp Re, Ltd. (Charp Re) (Turks & Caicos Islands). The outlook assigned to these Credit Ratings (ratings) is stable. The ratings reflect Charp Re’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management (ER...

AM Best Revises Outlooks to Positive for FMH Insurance Group’s Members

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has revised the outlooks to positive from stable and affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Farmers Mutual Hail Insurance Company of Iowa and its reinsured affiliate, FMH Ag Risk Insurance Company. Both companies are domiciled in West Des Moines, IA and are collectively referred to as FMH Insurance Group (FMH).The Credit Ratings (ratings) reflect FMH’s overall balance sheet str...

Best’s Commentary: Health Insurers Evaluating Balance Between Pharmacy Costs and Long-Term Value of GLP-1 Therapies

OLDWICK, N.J.--(BUSINESS WIRE)--As pharmacy cost trends continue to rise and clinical evidence evolves, health insurers face a fundamental question on whether improvements in long-term morbidity and the potential for improved mortality outcomes ultimately justify significant investments in GLP-1 therapies, according to a new AM Best commentary. The Best’s Commentary, “GLP-1 Therapies: Evaluating the Balance Between Pharmacy Costs and Long-Term Value,” states that GLP-1 therapies have become one...
Back to Newsroom